News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Krueger Christopher W
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Sold 14,006 shares
@ $29.9291, valued at
$419.2k
Sold 994 shares
@ $30.6959, valued at
$30.5k
Exercised 15,000 options to buy
@ $8.04, valued at
$120.6k
|
|
08/04/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Sold 13,300 shares
@ $35.5452, valued at
$472.8k
Sold 1,700 shares
@ $35.9094, valued at
$61k
Exercised 15,000 options to buy
@ $8.04, valued at
$120.6k
|
|
07/05/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Exercised 1,089 shares
@ $8.04, valued at
$8.8k
Exercised 13,911 shares
@ $0.2, valued at
$2.8k
Sold 403 shares
@ $33.5671, valued at
$13.5k
Sold 214 shares
@ $34.722, valued at
$7.4k
Sold 40 shares
@ $35.497, valued at
$1.4k
Sold 1,960 shares
@ $38.0477, valued at
$74.6k
Sold 2,150 shares
@ $38.7903, valued at
$83.4k
Sold 10,233 shares
@ $39.8703, valued at
$408k
Exercised 1,089 options to buy
@ $8.04, valued at
$8.8k
Exercised 13,911 options to buy
@ $0.2, valued at
$2.8k
|
|
06/06/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Sold 12,883 shares
@ $34.3105, valued at
$442k
Sold 2,117 shares
@ $34.6512, valued at
$73.4k
Exercised 4,716 options to buy
@ $8.04, valued at
$37.9k
Exercised 10,284 options to buy
@ $0.2, valued at
$2.1k
|
|
05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/05/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Exercised 7,972 shares
@ $3.54, valued at
$28.2k
Exercised 475 shares
@ $8.04, valued at
$3.8k
Sold 15,000 shares
@ $32.8777, valued at
$493.2k
Exercised 7,972 options to buy
@ $3.54, valued at
$28.2k
Exercised 475 options to buy
@ $8.04, valued at
$3.8k
|
|
01/18/2023 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Granted 108,750 options to buy
@ $33.84, valued at
$3.7M
Granted 18,125 restricted stock units
@ $0 |
|
12/20/2022 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Exercised 10,480 restricted stock units
@ $0 |
|
12/15/2022 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Sold 30,000 shares
@ $34.4556, valued at
$1M
|
|
12/06/2022 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Sold 50,000 shares
@ $29.0146, valued at
$1.5M
|
|
08/24/2022 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Exercised 96,778 options to buy
@ $0.2, valued at
$19.4k
Exercised 72,583 options to buy
@ $0.2, valued at
$14.5k
|
|
02/04/2022 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Granted 145,000 options to buy
@ $12.21, valued at
$1.8M
|
|
12/17/2021 |
4
| Krueger Christopher W (Chief Business Officer) has filed a Form 4 on Ventyx Biosciences, Inc.
Txns:
| Granted 41,916 options to buy
@ $14.48, valued at
$606.9k
Granted 41,917 restricted stock units
@ $0 |
|
07/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/24/2010 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns:
| Sold 3,000 shares
@ $21.9327, valued at
$65.8k
Exercised 3,000 options to buy
@ $5.2, valued at
$15.6k
|
|
05/26/2010 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns:
| Sold 3,000 shares
@ $22.9686, valued at
$68.9k
Exercised 3,000 options to buy
@ $5.2, valued at
$15.6k
|
|
05/18/2010 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns:
| Sold 1,145 shares
@ $23.1922, valued at
$26.6k
|
|
04/26/2010 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns:
| Sold 3,000 shares
@ $26.2392, valued at
$78.7k
Exercised 3,000 options to buy
@ $5.2, valued at
$15.6k
|
|
03/24/2010 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns:
| Sold 9,000 shares
@ $18.4538, valued at
$166.1k
Exercised 9,000 options to buy
@ $5.2, valued at
$46.8k
|
|
12/24/2009 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns:
| Sold 6,000 shares
@ $15.1136, valued at
$90.7k
Exercised 6,000 options to buy
@ $5.2, valued at
$31.2k
|
|
10/26/2009 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE |
09/24/2009 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE |
08/25/2009 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE |
05/21/2009 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE |
12/19/2008 |
4
| Krueger Christopher W (SVP & CBO) has filed a Form 4 on Ardea Biosciences, Inc./DE |
|
|